Skip to main content

Loading market data...

LIVN

LivaNova PLC

NASDAQ • United states

$78.98

-$0.73

(-0.92%)

Source: Yahoo Finance · Quote time Oct 21, 2026 18:50 GMT+0000

Management
Credibility
Score

LivaNova PLC (LIVN)

Unavailable

Quotes may be delayed

$4.35B

Market Cap

243,747

Volume

23.1

P/E Ratio

Unavailable

Div Yield

LivaNova PLC Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 20 EASTBOURNE TERRACE, LONDON, X0
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in LivaNova PLC.

5 Aug 2026

LivaNova PLC filed Form 10-Q

LivaNova PLC submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

5 Aug 2026

LivaNova PLC reported Operating or financial results

LivaNova PLC filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

11 Jun 2026

LivaNova PLC reported Shareholder voting results

LivaNova PLC filed an 8-K covering shareholder voting results, supporting financial statements or exhibits.

6 May 2026

LivaNova PLC filed Form 10-Q

LivaNova PLC submitted Form 10-Q to the SEC for the period ending Mar 31, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$516.62M

Total assets (USD)$2.64B

Total liabilities (USD)$1.32B

Shareholders' equity (USD)$1.33B

Long-term debt (USD)$289.91M

Debt due within a year (USD)$175,000

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$390.59M	$49.48M	$108.57M	$1.93	10-Q · 5 Aug 2026
Q1 2026	$362.26M	$41.47M	$22.29M	$0.40	10-Q · 6 May 2026
Q4 2025	$360.92M	$42.58M	$30.88M	Unavailable	10-K · 25 Feb 2026
Q3 2025	$357.75M	$54.01M	$26.78M	$0.49	10-Q · 5 Nov 2025
Q2 2025	$352.52M	$54.18M	$27.16M	$0.50	10-Q · 6 Aug 2025
Q1 2025	$316.86M	$48.62M	−$327.32M	−$6.01	10-Q · 7 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $89.60

13.4% upside potential

📈

Strong Buy

Unavailable

👍

Buy

5

⏸️

Hold

1

📉

Sell

0

6 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 18:50 UTC Targets range 75.00–105.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

10

Sep 2026

Bianchi Francesco

Director

Open-market sale

$78.01 per share

3,500 shares

4

Sep 2026

Story Brooke

Director

Open-market sale

$81.42 per share

2,300 shares

31

Aug 2026

Bianchi Francesco

Director

Open-market sale

$79.72 per share

1,650 shares

11

Aug 2026

Tezel Ahmet

Chief Innovation Officer

Option exercise

$52.68 per share

12,692 shares

11

Aug 2026

Tezel Ahmet

Chief Innovation Officer

Disposition to the company

$77.86 per share

8,589 shares

11

Aug 2026

Tezel Ahmet

Chief Innovation Officer

Tax withholding

$77.86 per share

1,428 shares

11

Aug 2026

Tezel Ahmet

Chief Innovation Officer

Open-market sale

$77.74 per share

2,675 shares

15

Jun 2026

WILVER PETER M

Director

Option exercise

Unavailable per share

4,042 shares

15

Jun 2026

WILVER PETER M

Director

Tax withholding

$79.70 per share

486 shares

15

Jun 2026

SCHERMERHORN TODD C

Director

Option exercise

Unavailable per share

4,042 shares

Top Shareholders

Blackrock, Inc.

7,565,342 shares

5.973% change

6/30/2026

Primecap Management Co/Ca/

4,168,377 shares

-0.919% change

6/30/2026

Fmr Llc

3,147,068 shares

18.015% change

6/30/2026

Hood River Capital Management Llc

2,565,477 shares

303.035% change

6/30/2026

Aqr Capital Management Llc

2,356,191 shares

-5.54% change

6/30/2026

Vanguard Group Inc

2,332,051 shares

1.515% change

12/31/2025

Invesco Ltd.

2,237,319 shares

37.748% change

6/30/2026

Artisan Partners Limited Partnership

2,224,763 shares

4.802% change

6/30/2026

State Street Corp

2,165,863 shares

4.496% change

6/30/2026

American Century Companies Inc

2,013,774 shares

12.192% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 18:50 UTC· 13 hours ago

Research coverage and investment tools

LivaNova PLC (LIVN) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus). Its last price was US$78.98 on 21 Oct 2026. That is 82% of the way from its 52-week low of US$48.82 to its 52-week high of US$85.76. Its market capitalisation was US$4.35 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$390.59M	$49.48M	$108.57M	$1.93	70.1%	12.7%	$35.04M	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$362.26M	$41.47M	$22.29M	$0.40	67.3%	11.4%	$926,000	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$360.92M	$42.58M	$30.88M	Unavailable	66.4%	11.8%	$50.16M	10-K · 25 Feb 2026 (opens in a new tab)
Q3 2025	$357.75M	$54.01M	$26.78M	$0.49	68.4%	15.1%	$62.18M	10-Q · 5 Nov 2025 (opens in a new tab)
Q2 2025	$352.52M	$54.18M	$27.16M	$0.50	67.8%	15.4%	$47.77M	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$316.86M	$48.62M	−$327.32M	−$6.01	68.3%	15.3%	$13.18M	10-Q · 7 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/5/2026	$1.02	$0.96	+6.3%
Mar 2026	5/6/2026	$0.87	$0.72	+20.8%
Dec 2025	2/25/2026	$0.73	$0.67	+9.0%
Sep 2025	11/5/2025	$0.97	$0.78	+24.4%

Cash and equivalents: $516.62M
Total assets: $2.64B
Total liabilities: $1.32B
Shareholders' equity: $1.33B
Long-term debt: $289.91M
Debt due within a year: $175,000

SCHEDULE 13G · 6 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in LivaNova PLC.
10-Q · 5 Aug 2026

LivaNova PLC filed Form 10-Q (opens in a new tab)

LivaNova PLC submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 5 Aug 2026

LivaNova PLC reported Operating or financial results (opens in a new tab)

LivaNova PLC filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 11 Jun 2026

LivaNova PLC reported Shareholder voting results (opens in a new tab)

LivaNova PLC filed an 8-K covering shareholder voting results, supporting financial statements or exhibits.
10-Q · 6 May 2026

LivaNova PLC filed Form 10-Q (opens in a new tab)

LivaNova PLC submitted Form 10-Q to the SEC for the period ending Mar 31, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Bianchi Francesco Director	10 Sep 2026	Open-market sale (S)	−3,500	$78.01	Form 4 (opens in a new tab)
Story Brooke Director	4 Sep 2026	Open-market sale (S)	−2,300	$81.42	Form 4 (opens in a new tab)
Bianchi Francesco Director	31 Aug 2026	Open-market sale (S)	−1,650	$79.72	Form 4 (opens in a new tab)
Tezel Ahmet Chief Innovation Officer	11 Aug 2026	Option exercise (M)	+12,692	$52.68	Form 4 (opens in a new tab)
Tezel Ahmet Chief Innovation Officer	11 Aug 2026	Disposition to the company (D)	−8,589	$77.86	Form 4 (opens in a new tab)
Tezel Ahmet Chief Innovation Officer	11 Aug 2026	Tax withholding (F)	−1,428	$77.86	Form 4 (opens in a new tab)
Tezel Ahmet Chief Innovation Officer	11 Aug 2026	Open-market sale (S)	−2,675	$77.74	Form 4 (opens in a new tab)
WILVER PETER M Director	15 Jun 2026	Option exercise (M)	+4,042	—	Form 4 (opens in a new tab)
WILVER PETER M Director	15 Jun 2026	Tax withholding (F)	−486	$79.70	Form 4 (opens in a new tab)
SCHERMERHORN TODD C Director	15 Jun 2026	Option exercise (M)	+4,042	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	7,565,342	5.973%
Primecap Management Co/Ca/	6/30/2026	4,168,377	-0.919%
Fmr Llc	6/30/2026	3,147,068	18.015%
Hood River Capital Management Llc	6/30/2026	2,565,477	303.035%
Aqr Capital Management Llc	6/30/2026	2,356,191	-5.54%
Vanguard Group Inc	12/31/2025	2,332,051	1.515%
Invesco Ltd.	6/30/2026	2,237,319	37.748%
Artisan Partners Limited Partnership	6/30/2026	2,224,763	4.802%
State Street Corp	6/30/2026	2,165,863	4.496%
American Century Companies Inc	6/30/2026	2,013,774	12.192%

Previous close: 79.71 USD
Day range: 78.34 – 81.25 USD
52-week range: 48.82 – 85.76 USD
Volume: 243,747
Market cap: $4.35B
Average volume: 618,123
P/E ratio: 23.1
EPS (FY 2025, diluted): −4.45 USD
Shares outstanding: 55.09M
Beta (5Y monthly): 0.93

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 18:50 UTC· 13 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:35 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for LIVN yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.